Markets:

Overview

News

Currencies

International

Treasuries

Sonnet BioTherapeutics Holdings, Inc. - Common Stock (NQ:SONN)

1.260 UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 2, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sonnet BioTherapeutics Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stocks That Hit 52-Week Lows On Wednesday ↗

April 19, 2023

During Wednesday's trading, 123 companies set new 52-week lows.

Via Benzinga

Analyst Says Sonnet BioTherapeutics Highlighted Encouraging Data For SON-1010 At AACR Meet ↗

April 19, 2023

Via Benzinga

Why Sonnet BioTherapeutics Shares Are Trading Lower By Around 13%; Here Are 20 Stocks Moving Premarket ↗

April 19, 2023

Gainers Clearmind Medicine Inc. (NASDAQ: CMND) jumped 69.3% to $0.8480 in pre-market trading after dropping 12% on Tuesday. Clearmind Medicine recently announced a $3.5 million public offering priced...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

March 15, 2023

On Wednesday, 479 stocks made new 52-week lows.

Via Benzinga

Sonnet Bio Reveals Pharmacokinetic, Pharmacodynamic Data In Early-Stage SON-1010 Trial ↗

January 19, 2023

Via Benzinga

Sonnet BioTherapeutics Announces Updated Clinical Data for SON-1010 at the 2023 American Association for Cancer Research (AACR) Annual Meeting

April 18, 2023

Via ACCESSWIRE

Sonnet BioTherapeutics Announces Webcast to Discuss Clinical Data from the SB101 Study with SON-1010 Being Presented at the AACR 2023 Annual Meeting

April 17, 2023

Via ACCESSWIRE

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 27, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

March 27, 2023

On Monday, 89 stocks made new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 27, 2023

Via Benzinga

Allbirds And 3 Other Stocks Under $2 Insiders Are Aggressively Buying ↗

March 17, 2023

The Dow Jones closed higher by more than 350 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Sonnet BioTherapeutics to Present Clinical Data from the SB101 Study with SON-1010 at the AACR 2023 Annual Meeting

March 14, 2023

Via ACCESSWIRE

Why Cassava Sciences Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗

March 09, 2023

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 14, 2023

Tuesday's morning session saw 84 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

February 27, 2023

During Monday's session, 56 companies made new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 24, 2023

On Friday, 135 companies reached new 52-week lows.

Via Benzinga

InvestorNewsBreaks – Sonnet BioTherapeutics Holdings Inc. (NASDAQ: SONN) Releases Pricing of Underwritten Public Offering to Total Estimated $15M

February 14, 2023

Via Investor Brand Network

Sonnet BioTherapeutics Provides Fiscal Year 2023 First Quarter Business and Earnings Update

February 13, 2023

Via ACCESSWIRE

Why Sonnet BioTherapeutics (SONN) Shares Are Falling ↗

February 08, 2023

Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares are trading lower by 12.97% to $0.94 Wednesday morning after the company announced pricing of a $15 million underwritten public offering....

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 08, 2023

Via Benzinga

Sonnet BioTherapeutics Announces Pricing of $15.0 Million Underwritten Public Offering

February 08, 2023

Via ACCESSWIRE

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

February 08, 2023

Our coverage starts today with a look at the biggest pre-market stock movers traders will want to keep an eye on Wednesday!

Via InvestorPlace

Sonnet BioTherapeutics Announces Successful Completion of Two IND-Enabling Toxicology Studies with SON-1210 in Non-Human Primates

February 01, 2023

Via ACCESSWIRE

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 30, 2023

Via Benzinga

Why FARO Technologies Shares Are Trading Lower By 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 20, 2023

Gainers Helbiz, Inc. (NASDAQ: HLBZ) shares jumped 133.1% to $0.2870. Helbiz recently announced discontinuation of operations in non-profitable markets.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 20, 2023

Via Benzinga

Why Netflix Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket ↗

January 20, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 20, 2023

It's the final day of trading this week and we're checking in on the biggest pre-market stock movers for Friday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 19, 2023

Via Benzinga

Sonnet BioTherapeutics Announces Pharmacokinetic and Pharmacodynamic Data in a Phase 1 Dose-Escalation Trial of SON-1010

January 19, 2023

Via ACCESSWIRE

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sonnet BioTherapeutics Holdings, Inc. - Common Stock (NQ:SONN)

All News about Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today